EUVIMEDEUVIMED entdecken
Crossref

Nose-to-Brain Targeted Mucoadhesive Nanoemulsion for Management of Schizophrenia: Development and Pharmacodynamic Evaluation

Rashmin Patel, Shivam Thakore, Jigar Vanza, Mitali Patel, Ajay Solanki, Richa Dave, Mrunali Patel

Journal of Pharmaceutical Innovation · 2027-02 · 22 (1)

DOI: 10.1007/s12247-026-10893-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical Innovation, online erschienen am 14.08.2026. Verfasst von Rashmin Patel und 6 weiteren Autor:innen. Die Arbeit nennt 38 Literaturangaben. Gefördert von: Department of Science and Technology, Ministry of Science and Technology, India.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • Department of Science and Technology, Ministry of Science and Technology, India

Zitieren

APA

Patel, R., Thakore, S., Vanza, J., Patel, M., Solanki, A., Dave, R., & Patel, M. (2027). Nose-to-Brain Targeted Mucoadhesive Nanoemulsion for Management of Schizophrenia: Development and Pharmacodynamic Evaluation. Journal of Pharmaceutical Innovation, 22(1). https://doi.org/10.1007/s12247-026-10893-4

Vancouver

Patel R, Thakore S, Vanza J, Patel M, Solanki A, Dave R, et al. Nose-to-Brain Targeted Mucoadhesive Nanoemulsion for Management of Schizophrenia: Development and Pharmacodynamic Evaluation. Journal of Pharmaceutical Innovation. 2027;22(1). doi:10.1007/s12247-026-10893-4

BibTeX
@article{Patel2027,
  author = {Patel, Rashmin and Thakore, Shivam and Vanza, Jigar and Patel, Mitali and Solanki, Ajay and Dave, Richa and Patel, Mrunali},
  title = {Nose-to-Brain Targeted Mucoadhesive Nanoemulsion for Management of Schizophrenia: Development and Pharmacodynamic Evaluation},
  journal = {Journal of Pharmaceutical Innovation},
  year = {2027},
  volume = {22},
  number = {1},
  doi = {10.1007/s12247-026-10893-4}
}
Kostenlos starten →